VELARU MANDATE EXHIBIT PACK — SYNTHETIC BIOLOGY / BIOSECURITY
Jurisdiction: Florida (us_fl)
Modality: Text / Chat
Program: Velaru Synthetic Biology / Biosecurity · Florida (galactic_synthetic_biology_us_fl)
Product ID: synthetic_biology:us_fl:bundle:text
Vertical: synthetic_biology
Generated: 2026-08-22T06:09:43.477382Z
Authority: Florida OIR AI Pack — Biosecurity AI Screening Pack
Deadline: Federal Select Agent Program + DURC
Velaru verify: https://velaru-erra.onrender.com/verify

EXHIBIT A — AI INVENTORY
[]

EXHIBIT B — GOVERNANCE FRAMEWORK
{
  "framework": "Velaru Mandate Registry \u2014 Synthetic Biology / Biosecurity",
  "exhibit_authority": "Florida OIR AI Pack \u2014 Biosecurity AI Screening Pack",
  "regulatory_frameworks": [
    "Federal Select Agent Program",
    "NIH Guidelines",
    "DURC Policy",
    "FL HB 919",
    "Florida Information Protection Act",
    "Citizens Property Insurance"
  ],
  "standards_alignment": [
    "POSS-2",
    "DRP-1",
    "TCB",
    "FRE 707 pre-compliance",
    "ISO 42001"
  ],
  "human_oversight": "synthesize DNA sequence",
  "third_party_verification": "https://velaru-erra.onrender.com/verify (operator-independent)",
  "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor",
  "mirror_trap": "Cloud lab orders sequence \u2014 lab owns biosecurity violation, screening vendor owns API uptime SLA. \u00b7 Florida property insurers using AI for claims while Citizens backs up market \u2014 AI claim denial = political lightning rod.",
  "chain_integrity": {
    "depth": 5,
    "invariant_holds": true
  }
}

EXHIBIT D — DATA INPUTS & VALIDATION
{
  "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator",
  "bias_testing_proxy": "Asymmetry score from live chain signals",
  "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute",
  "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks",
  "external_validator": "Nisaba LLC / Velaru",
  "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional",
  "headline_stat": "Screening AI failure = criminal liability under Select Agent regulations",
  "global_leaders_addressed": [
    "CDC",
    "Ginkgo Bioworks",
    "Twist Bioscience",
    "NIH",
    "WHO",
    "Florida OIR",
    "Citizens Property",
    "Universal Property"
  ]
}

MIRROR TRAP (regulatory insight)
Cloud lab orders sequence — lab owns biosecurity violation, screening vendor owns API uptime SLA. · Florida property insurers using AI for claims while Citizens backs up market — AI claim denial = political lightning rod.

NERVE CARDS — WHY GLOBAL LEADERS CARE
[
  {
    "title": "DURC policy",
    "body": "Dual use research of concern \u2014 AI screening decision must be documented for IBC review.",
    "source": "vertical"
  },
  {
    "title": "Sequence orders",
    "body": "Every synthesis order needs screening receipt \u2014 HHS 2010 framework now AI-accelerated.",
    "source": "vertical"
  },
  {
    "title": "Insurance exclusion",
    "body": "Biotech policies excluding unscreened AI sequence design.",
    "source": "vertical"
  },
  {
    "title": "[Florida] Hurricane claims AI",
    "body": "Post-Idalia/Ian claims AI scrutiny \u2014 bad faith with AI lowball estimate.",
    "source": "jurisdiction"
  },
  {
    "title": "[Florida] Surplus lines",
    "body": "Florida largest homeowners market collapse \u2014 AI underwriting receipt mandatory for OIR exam.",
    "source": "jurisdiction"
  },
  {
    "title": "[Text / Chat] Modality hook",
    "body": "Baseline \u2014 all frameworks apply to text decisions.",
    "source": "modality"
  }
]

BOOK SUMMARY: {
  "total_insureds": 0,
  "compliant": 0,
  "grace_period": 0,
  "non_compliant": 0,
  "expired": 0,
  "not_enrolled": 0,
  "compliant_pct": 0.0
}

TAM / EXPOSURE: Synthetic biology market $80B+ · DNA synthesis screening mandatory
INSURANCE LINES: Biotech E&O, Product liability

DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.